" class="no-js "lang="en-US"> Oncology Archives - Medtech Alert
Saturday, April 01, 2023

Sort by:

Date

Top Post

NHS Slashes Longest Elective and Cancer Patient Waiting Lists

The number of people waiting over 18 months for NHS care has fallen again despite […]

Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China

Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted Radiotherapy (TRT) to benefit […]

Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics

Trobix Bio, a company utilizing CRISPR, phage, and synthetic biology technologies to develop advanced precision […]

BGI Genomics Partners with Zentya to Launch Fecal DNA Test for Colorectal Cancer in Slovakia

BGI Genomics is pleased to announce the launch of COLOTECTTM 1.0 in Slovakia, in collaboration […]

Lantern Pharma Announces First Patient Dosed in Study for LP-300 in Never Smokers with Advanced Non-Small Cell Lung Cancer

Lantern Pharma, a clinical-stage biopharmaceutical company using its proprietary RADR® artificial intelligence and machine learning […]

MIMETAS and Astellas Enter into Strategic Partnership

MIMETAS, a global leader in human disease modeling, announces that it has entered into a […]

First New Life-extending NHS Treatment for Incurable Cervical Cancer in Almost 15 Years

A life-extending treatment for advanced cervical cancer will be made available to hundreds of NHS […]

FLASH Proton Therapy Clinical Trial Begins on Cancers Involving Bones in the Chest

Treatment of the first participant in a clinical trial of FLASH proton therapy for cancers […]

Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize T Cell Therapies

Sonoma Biotherapeutics and Regeneron Pharmaceuticals today announced a collaboration to apply their scientific and clinical expertise […]

Phase III RUBY Clinical Trial Shows Jemperli Could Redefine Cancer Treatment

GSK today announced interim results from Part 1 of the RUBY/ENGOT-EN-6-NSGO/GOG3031 phase III trial investigating […]

NHS Slashes Longest Elective and Cancer Patient Waiting Lists

The number of people waiting over 18 months for NHS care has fallen again despite […]

  1. Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis Read more
  2. NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business Read more
  3. Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Read more
  4. Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Read more
  5. Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Read more